Tomáš Cihlář
- Infectious Diseases top 0.05%
- Epidemiology top 0.5%
- Virology top 0.1%
- Molecular Biology top 5%
- Oncology top 2%
- Co-authors
- Adrian S. RayGabriel BirkušRobert JordanEdmund HoAndrew MulatoJoy Y. FengTimothy P. SheahanRalph S. Baric
- Topics
- HIV/AIDS drug development and treatment (76 papers)HIV Research and Treatment (57 papers)HIV/AIDS Research and Interventions (21 papers)
- Partner nations
- United StatesCzechiaBelgium
In The Last Decade
Tomáš Cihlář
140 papers receiving 11.1k citations
Hit Papers
Peers
Comparison fields: 5 of 143
- Infectious Diseases 7.8k
- Epidemiology 2.8k
- Virology 2.6k
- Molecular Biology 2.2k
- Oncology 1.3k
Countries citing papers authored by Tomáš Cihlář
This map shows the geographic impact of Tomáš Cihlář's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomáš Cihlář with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomáš Cihlář more than expected).
Fields of papers citing papers by Tomáš Cihlář
This network shows the impact of papers produced by Tomáš Cihlář. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomáš Cihlář. The network helps show where Tomáš Cihlář may publish in the future.
Co-authorship network of co-authors of Tomáš Cihlář
This figure shows the co-authorship network connecting the top 25 collaborators of Tomáš Cihlář. A scholar is included among the top collaborators of Tomáš Cihlář based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomáš Cihlář. Tomáš Cihlář is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 5 | |
| 3 | Mutations in the SARS-CoV-2 RNA-dependent RNA polymerase confer resistance to remdesivir by distinct mechanismsbreakdown → | 139 |
| 4 | 48 | |
| 5 | 0 | |
| 6 | NRTIs tenofovir, TAF, TDF, and FTC are inactive against SARS-CoV-2 | 0 |
| 7 | 31 | |
| 8 | 50 | |
| 9 | 142 | |
| 10 | 116 | |
| 11 | 81 | |
| 12 | 97 | |
| 13 | 224 | |
| 14 | 100 | |
| 15 | 83 | |
| 16 | 269 | |
| 17 | 9 | |
| 18 | 16 | |
| 19 | 70 | |
| 20 | 67 |
About Tomáš Cihlář
Tomáš Cihlář is a scholar working on Virology, Infectious Diseases and Epidemiology, having authored 143 papers that have together received 11.3k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (76 papers), HIV Research and Treatment (57 papers) and HIV/AIDS Research and Interventions (21 papers). The work is most often cited by research in Virology (2.6k citations), Infectious Diseases (7.8k citations) and Epidemiology (2.8k citations). Tomáš Cihlář has collaborated with scholars based in United States, Czechia and Belgium. Frequent co-authors include Adrian S. Ray, Gabriel Birkuš, Robert Jordan, Edmund Ho, Andrew Mulato, Joy Y. Feng, Timothy P. Sheahan, Ralph S. Baric, Mark R. Denison and Michael D. Fuller. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nature Medicine and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.